Purchase Order 75N98026P01439
Award Date 9/1/26
Potential Completion Date 8/31/27
Potential Value $75K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Integrated Biotherapeutics, LLC for $30,271 on June 28, 2019. The order, a firm fixed price acquisition for antibodies, carries no set-aside designation. Work is performed in Rockville, Maryland. Ultimate completion is July 28, 2019. The vendor is a self-certified small disadvantaged business specializing in biomedical research and laboratory testing services.</p>
- The National Institute of Dental and Craniofacial Research awarded a purchase order to Integrated Biotherapeutics, LLC for $10,530.00 on April 25, 2018. The order, for firm fixed price, calls for evaluation of 80 samples using the HCTYMSG Millipore PX38 on a Luminex platform. Performance occurs in Bethesda, Maryland, with an ultimate completion date of May 30, 2018. Integrated Biotherapeutics is a self-certified small disadvantaged business based in Rockville, Maryland, specializing in...
- This contract was awarded by the National Cancer Institute, a civilian agency within the U.S. government, to Integrated Biotherapeutics, LLC (doing business as IBT Bio Services), a small disadvantaged business. The $17,964 firm fixed-price purchase order is for laboratory and testing services, with a period of performance ending on May 26, 2026. IBT Bio Services has a history of providing biomedical research and infectious disease response services to federal agencies through prior contract...
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to System Biosciences, LLC for $20,480 on September 22, 2020, under a Total Small Business set-aside. The order, set for completion by November 20, 2020, procures exosome surface and membrane protein profiling services at the place of performance in Bethesda, Maryland. System Biosciences is an Asian-Pacific American–owned small business specializing in exosome research and advanced molecular biology services.
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $19,146.40 firm fixed-price purchase order to Global Life Sciences Solutions USA LLC for an 8-month service contract to provide Biacore 8K v2 instrumentation. The prime contractor, a subsidiary of Danaher Corporation, will deliver the requested biotechnology analytical equipment and associated services at the agency's facility in Bethesda, Maryland between...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $20,623 purchase order to Life Technologies Corporation for the delivery of CYTOKINE 30-PLEX HUMAN PANELS. As the prime contractor, Life Technologies Corporation will provide the requested cytokine panels to support NIH research efforts studying allergies and infectious diseases. The firm fixed price contract runs from September 21, 2023 through November...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for $19,760.00 on June 21, 2019, with ultimate completion on July 21, 2019. Place of performance is Bethesda, Maryland. The order covers laboratory supplies and consumables, priced on a firm fixed price basis with no set-aside designation.</p>
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Adaptive Biotechnologies Corporation for $20,000 on July 11, 2019, with an ultimate completion date of July 11, 2020. Work is performed at Bethesda, Maryland. The order procures immunosequencing services under firm fixed-price commercial terms. No set-aside was used.</p>
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,345.50 purchase order to Biointron Biological USA Inc. for antibody expression services. As a firm fixed price contract, Biointron will provide the requested antibody expression services to NIH/NIAID at Metuchen, New Jersey from September 19, 2023 through December 29, 2023. No subcontractors or set aside designations were indicated. NIAID conducts and...